Skip to main content

Science and Ethics at NIH--and FDA

Many of the headlines suggested that the proposed ethics rules for NIH employees have been relaxed. But that's not quite true, as Ted Agres pointed out here. The rules on stock ownership have loosened, yes. But the most important restriction remains. That's the one forbidding those who labor at NIH to do outside consulting for businesses with a stake in NIH's labor.These decisions are a smart move for NIH director Elias A. Zerhouni. The previous proposed stock ownership rules were needl

Written byTabitha M. Powledge
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Many of the headlines suggested that the proposed ethics rules for NIH employees have been relaxed. But that's not quite true, as Ted Agres pointed out here. The rules on stock ownership have loosened, yes. But the most important restriction remains. That's the one forbidding those who labor at NIH to do outside consulting for businesses with a stake in NIH's labor.These decisions are a smart move for NIH director Elias A. Zerhouni. The previous proposed stock ownership rules were needlessly restrictive on most employees. The new stock rules will please them, yet also retain some restrictions on NIH's most senior people. It looks to be a sensible compromise that will reduce opportunities for mischief while making it somewhat less difficult to recruit world-class scientists. But Zerhouni stood firm against the activities that offer the most serious opportunities for corruption of the scientific process: outside consulting for pharmas, biotechs, and related industries. That's the right thing to do, and it's also smart PR. It can't hurt NIH's reputation with the public--or with Congress--that Zerhouni seems serious about trying to keep the agency's science pure.By contrast, on Friday the FDA once again postponed a decision on allowing nonprescription sales of Plan B, the morning-after contraceptive. This is still another craven cave-in to political pressure from the religious right--to say nothing of a repudiation of the scientific committees whose advice the agency is supposed to be taking, which favored wider availability. In these Washington Dog Days, displaying even a little backbone, as Zerhouni did, makes him look like a candidate for canonization.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo